Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 1
1996 4
1997 6
1998 12
1999 4
2000 4
2001 7
2002 6
2003 8
2004 4
2005 6
2006 14
2007 2
2008 2
2009 5
2010 2
2011 1
2012 6
2013 10
2014 12
2015 5
2016 4
2017 2
2018 3
2019 3
2020 1
2021 4
2022 2
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

136 results

Results by year

Filters applied: . Clear all
Page 1
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis.
Silverberg JI, Guttman-Yassky E, Thaçi D, Irvine AD, Stein Gold L, Blauvelt A, Simpson EL, Chu CY, Liu Z, Gontijo Lima R, Pillai SG, Seneschal J; ADvocate1 and ADvocate2 Investigators. Silverberg JI, et al. N Engl J Med. 2023 Mar 23;388(12):1080-1091. doi: 10.1056/NEJMoa2206714. Epub 2023 Mar 15. N Engl J Med. 2023. PMID: 36920778 Clinical Trial.
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.
Simpson EL, Bieber T, Guttman-Yassky E, Beck LA, Blauvelt A, Cork MJ, Silverberg JI, Deleuran M, Kataoka Y, Lacour JP, Kingo K, Worm M, Poulin Y, Wollenberg A, Soo Y, Graham NM, Pirozzi G, Akinlade B, Staudinger H, Mastey V, Eckert L, Gadkari A, Stahl N, Yancopoulos GD, Ardeleanu M; SOLO 1 and SOLO 2 Investigators. Simpson EL, et al. N Engl J Med. 2016 Dec 15;375(24):2335-2348. doi: 10.1056/NEJMoa1610020. Epub 2016 Sep 30. N Engl J Med. 2016. PMID: 27690741 Free article. Clinical Trial.
KAAACI Guidelines for Allergen Immunotherapy.
Lee HY, Lee SM, Kang SY, Kim K, Kim JH, Ryu G, Min JY, Park KH, Park SY, Sung M, Lee Y, Yang EA, Jee HM, Ha EK, Shin YS, Chung EH, Choi SH, Koh YI, Kim ST, Nahm DH, Park JW, Shim JY, An YM, Han DH, Han MY, Lee YW, Choi JH; Korean Academy of Asthma Allergy and Clinical Immunology (KAAACI) Allergen Immunotherapy and Allergen Working Group. Lee HY, et al. Among authors: nahm dh. Allergy Asthma Immunol Res. 2023 Nov;15(6):725-756. doi: 10.4168/aair.2023.15.6.725. Allergy Asthma Immunol Res. 2023. PMID: 37957792 Free PMC article. Review.
The KAAACI Guidelines for Sublingual Immunotherapy.
Min JY, Jee HM, Lee HY, Kang SY, Kim K, Kim JH, Park KH, Park SY, Sung M, Lee Y, Yang EA, Ryu G, Ha EK, Lee SM, Lee YW, Chung EH, Choi SH, Koh YI, Kim ST, Nahm DH, Park JW, Shim JY, An YM, Han MY, Choi JH, Shin YS, Han DH; on the behalf of the Korean Academy of Asthma Allergy and Clinical Immunology (KAAACI) Allergen Immunotherapy and Allergen Working Group. Min JY, et al. Among authors: nahm dh. Allergy Asthma Immunol Res. 2024 Jan;16(1):9-21. doi: 10.4168/aair.2024.16.1.9. Allergy Asthma Immunol Res. 2024. PMID: 38262388 Free PMC article. Review.
Clusters of Severe Eosinophilic Asthma in a Korean Asthma Cohort.
Lee JH, An J, Won HK, Seo B, Kim JH, Park SY, Kim MH, Shin YS, Jung JW, Song WJ, Lee T, Kwon HS, Lee JH, Kim JH, Kim SH, Chang YS, Cho YS, Nahm DH, Jang AS, Park JW, Yoon HJ, Cho SH, Cho YJ, Choi BW, Moon HB, Kim TB; COREA Investigators. Lee JH, et al. Among authors: nahm dh. Respiration. 2022;101(5):465-475. doi: 10.1159/000520492. Epub 2021 Dec 16. Respiration. 2022. PMID: 34915526
Clinical characteristics of angioedema with eosinophilia.
Cho HJ, Yoo HS, Kim MA, Shin YS, Ye YM, Nahm DH, Kim JH, Choi JH, Park SY, Park HS. Cho HJ, et al. Among authors: nahm dh. Allergy Asthma Immunol Res. 2014 Jul;6(4):362-5. doi: 10.4168/aair.2014.6.4.362. Epub 2014 Jan 29. Allergy Asthma Immunol Res. 2014. PMID: 24991461 Free PMC article.
136 results